1. Home
  2. Analysis
  3. Isosorbide-mononitrate
  4. Eloxatin

Isosorbide mononitrate and Eloxatin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Isosorbide mononitrate (isosorbide mononitrate) and Eloxatin (oxaliplatin). Common drug interactions include chest pain among males.

The phase IV clinical study analyzes what interactions people have when they take Isosorbide mononitrate and Eloxatin. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Isosorbide mononitrate?

Isosorbide mononitrate has active ingredients of isosorbide mononitrate. It is often used in angina. eHealthMe is studying from 26,858 Isosorbide mononitrate users. Check the latest studies of Isosorbide mononitrate.

What is Eloxatin?

Eloxatin has active ingredients of oxaliplatin. eHealthMe is studying from 7,092 Eloxatin users. Check the latest studies of Eloxatin.

On Jul, 20, 2026

11 people who take Isosorbide mononitrate and Eloxatin together, and have interactions are studied.

Isosorbide mononitrate and Eloxatin drug interactions.

What are the common drug interactions of Isosorbide Mononitrate and Eloxatin, by gender? *:

female:

n/a

male:

  1. Chest pain
  2. Anaemia (lack of blood)
  3. Arteriospasm coronary (spasm of the large- or medium-sized coronary arteries)
  4. Acute myocardial infarction (acute heart attack)
  5. Chest discomfort
  6. Dyspnoea (difficult or laboured respiration)
  7. Fatigue (feeling of tiredness)
  8. Hyperhidrosis (abnormally increased sweating)
  9. Insomnia (sleeplessness)
  10. Nausea (feeling of having an urge to vomit)

What are the common drug interactions of Isosorbide Mononitrate and Eloxatin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Chest pain
  2. Anaemia (lack of blood)
  3. Acute myocardial infarction (acute heart attack)
  4. Chest discomfort
  5. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  6. Dyspnoea (difficult or laboured respiration)
  7. Fatigue (feeling of tiredness)
  8. Hyperhidrosis (abnormally increased sweating)
  9. Insomnia (sleeplessness)
  10. Nausea (feeling of having an urge to vomit)

What are the existing conditions these people have? *

  1. Gastric Cancer (stomach cancer): 4 people, 36.36%
  2. Colon Cancer: 2 people, 18.18%
  3. Metastatic Gastric Cancer (cancer types can spread to the stomach from other place): 1 person, 9.09%
  4. Metastatic Carcinoma Of The Bladder (cancer types can spread to the bladder from other place): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Isosorbide mononitrate and Eloxatin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Isosorbide mononitrate and Eloxatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Isosorbide mononitrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Eloxatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Isosorbide mononitrate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Eloxatin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on isosorbide mononitrate and oxaliplatin (the active ingredients of Isosorbide mononitrate and Eloxatin, respectively), and Isosorbide mononitrate and Eloxatin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.